Jump to navigation

  • Contact us
  • Data catalog (GHDx)
  • Research library
Home
Main menu
  • Home
  • Research and analysis
    • Global Burden of Disease (GBD)
    • Health policy and planning
    • Health by location
    • Health risks and issues
    • Diseases and conditions
    • Training on our research
    • Research and news library
  • Data tools and practices
    • Interactive data visuals
    • Data sources
    • How we collect data
    • Data practices
    • Verbal autopsy tool
    • Training on tools
    • Data for the private sector
  • News and events
    • News media
    • Blogs
    • Events
    • Media contacts
  • About us
    • Mission and vision
    • Diversity, Equity, and Inclusion
    • Our people
    • Awards
    • Careers
    • History
    • Governance
    • Contact us

Explore section

Research & Analysis

  • Global Burden of Disease (GBD)
  • Health policy and planning
  • Health by location
  • Health risks and issues
  • Diseases and conditions
  • Training on our research
  • Research and news library

Intimate partner violence — Level 2 risk


Summary Among females, intimate partner violence (IPV) was the 19th-leading Level 2 risk factor for DALYs globally in 2019. IPV was responsible for 11·0% (95% UI 0·1–24·0) of DALYs due to depressive disorders and 13·9% (7·2–21·6) of DALYs due to HIV in females.

Definition IPV is defined as any lifetime experience of physical or sexual violence perpetrated by a current or former intimate partner, and is estimated among females only. Outcomes are major depression, interpersonal violence, and HIV/AIDS. The TMREL is no IPV.

Total sources
Exposure 601
Relative risk 9
Table 1: Total sources used in GBD 2019 estimation
What is new in GBD 2019?
  • •For non-reference data, correction factors were re-estimated using a logit-difference model in MR-BRT, whereas in GBD 2017 these were estimated as fixed effects in a DisMod-MR model. This more rigorous approach led to a mean global increase in estimates of IPV exposure by approximately 20%.
  • •The relative risk for depression and HIV given IPV were calculated using MR-BRT, replacing a random effects meta-analysis from GBD 2017. Relative risk changed from 1·46 (1·09–1·91) to 1·54 (1·00–2·36) for major depression, and 1·59 (1·29–1·92) to 1·60 (1·31–1·93) for HIV.
  • •IPV ceased to be calculated as a risk factor for abortion, due to a judgement of insufficient evidence supporting a causal relationship after re-evaluating sources used in previous GBD rounds.
Deaths
YLLs
YLDs
DALYs
Number
(millions)
Rate (per
100 000)
Number
(millions)
Rate (per
100 000)
Number
(millions)
Rate (per
100 000)
Number
(millions)
Rate (per
100 000)
2019
Both Sexes
0·0865 (0·0549
to 0·125)
1·1 (0·7
to 1·5)
4·12 (2·60
to 6·04)
50·8 (32·2
to 74·5)
4·38 (1·11
to 8·23)
53·7 (13·6
to 101·0)
8·50 (4·44
to 13·3)
104·5 (54·7
to 163·2)
Females
0·0865 (0·0549
to 0·125)
2·1 (1·3
to 3·1)
4·12 (2·60
to 6·04)
102·1 (64·7
to 149·9)
4·38 (1·11
to 8·23)
107·1 (27·1
to 201·6)
8·50 (4·44
to 13·3)
209·2 (109·8
to 326·7)
Males
0 (0
to 0)
-–
0 (0
to 0)
-–
0 (0
to 0)
-–
0 (0
to 0)
-–
Percentage change 2010-19
Both Sexes
–36·4% (–40·3
to –30·5)
–43·8% (–47·1
to –38·6)
–38·3% (–42·2
to –32·1)
–44·6% (–48·1
to –38·8)
14·6% (3·9
to 19·9)
1·0% (–6·8
to 5·0)
–19·1% (–33·9
to –6·6)
–27·9% (–40·8
to –17·5)
Females
–36·4% (–40·3
to –30·5)
–43·9% (–47·1
to –38·7)
–38·3% (–42·2
to –32·1)
–44·6% (–48·0
to –38·8)
14·6% (3·9
to 19·9)
1·0% (–6·7
to 5·1)
–19·1% (–33·9
to –6·6)
–27·9% (–40·8
to –17·5)
Males
-–
-–
-–
-–
-–
-–
-–
-–
Numbers in parentheses are 95% uncertainty intervals.
Table 2: Attributable global deaths, YLLs, YLDs, and DALYs in counts and age-standardised rates for both sexes combined, females, and males, 2019, with percentage change between 2010 and 2019
Deaths YLLs YLDs DALYs
1990 19th 19th 17th 19th
2010 19th 19th 18th 19th
2019 19th 19th 17th 19th
Table 3: Rank among attributable Level 2 risks of global deaths, YLLs, YLDs, and DALYs in 1990, 2010, and 2019 for both sexes combined
Figure 1: Composition of attributable global DALYs by constituent Level 2 causes for both sexes combined, 2019
Figure 2: Composition of attributable global DALYs by YLLs and YLDs, age group, and sex, 2019
No Legend
Figure 3: Age-standardised all-cause SEV by location, both sexes combined, 2019
No Legend
Figure 4: Percentage change in all-cause age-standardised SEV by SDI, both sexes combined, 1990–2019
Figure 5: Percentage of population exposed to risk factor, both sexes combined, 2019
Figure 6: All-cause mortality relative risk, both sexes combined, 2019

Research & Analysis

  • Global Burden of Disease (GBD)
  • Health policy and planning
  • Health by location
  • Health risks and issues
  • Diseases and conditions
  • Training on our research
  • Research and news library

Stay connected

    

Sign up for our newsletter

  • Contact us
  • Donate
  • Privacy policy

© 2023

         Home to Highly Cited Researchers 2022, Clarivate

  • Home
  • Research and analysis
    • Global Burden of Disease (GBD)
    • Health policy and planning
    • Health by location
    • Health risks and issues
    • Diseases and conditions
    • Training on our research
    • Research and news library
  • Data tools and practices
    • Interactive data visuals
    • Data sources
    • How we collect data
    • Data practices
    • Verbal autopsy tool
    • Training on tools
    • Data for the private sector
  • News and events
    • News media
    • Blogs
    • Events
    • Media contacts
  • About us
    • Mission and vision
    • Diversity, Equity, and Inclusion
    • Our people
    • Awards
    • Careers
    • History
    • Governance
    • Contact us